Werewolf Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22%.

Top 25 shareholders own 89% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.1%	RA Capital Management, L.P.	6,144,881	US$15.4m	0%	0.22%
9.86%	MPM Asset Management, L.L.C.	4,284,172	US$10.8m	0%	4.46%
6.92%	PFM Health Sciences, LP	3,006,734	US$7.5m	-13.3%	0.43%
6.91%	Adage Capital Management, L.P.	3,000,594	US$7.5m	-1.11%	0.01%
5.5%	BioImpact Capital LLC	2,388,011	US$6.0m	0%	1.13%
4.76%	Taiho Ventures, LLC	2,068,909	US$5.2m	0%	no data
4.71%	Alon Lazarus	2,046,634	US$5.1m	0%	no data
4.71%	Arkin Bio Venture Partners Ltd.	2,046,634	US$5.1m	0%	7.73%
4.32%	Bank of America Corporation, Asset Management Arm	1,877,613	US$4.7m	-9.9%	no data
3.88%	Janus Henderson Group plc	1,688,054	US$4.2m	0%	no data
3.86%	Longwood Fund	1,677,082	US$4.2m	0%	100.0%
3.73%	Rubric Capital Management LP	1,621,034	US$4.1m	-16.2%	0.09%
2.55%	The Vanguard Group, Inc.	1,107,347	US$2.8m	26.8%	no data
2.05%	Monashee Investment Management, LLC	890,000	US$2.2m	0%	0.28%
1.61%	Eagle Health Investments LP	700,000	US$1.8m	0%	0.35%
1.49%	Daniel Hicklin	647,047	US$1.6m	0%	no data
1.44%	Sphera Funds Management Ltd	626,810	US$1.6m	0%	0.28%
1.36%	Dean Capital Investments Management, LLC	589,102	US$1.5m	0%	1.29%
1.32%	Verition Fund Management LLC	571,466	US$1.4m	0%	0.02%
1.3%	Millennium Management LLC	565,417	US$1.4m	27.2%	no data
0.6%	Geode Capital Management, LLC	259,680	US$651.8k	33.6%	no data
0.57%	Two Sigma Advisers, LP	247,600	US$621.5k	39.7%	no data
0.54%	Alyeska Investment Group, L.P.	235,705	US$591.6k	-45.9%	no data
0.46%	Laurion Capital Management LP	201,236	US$505.1k	154%	0.02%
0.43%	Two Sigma Investments, LP	185,059	US$464.5k	26.1%	no data